Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Sarepta Therapeutics (SRPT)

Sarepta Therapeutics (SRPT)
74.33 -5.64 (-7.05%) 14:18 ET [NASDAQ]
74.16 x 100 74.35 x 6
Realtime by (Cboe BZX)
74.16 x 100 74.35 x 6
Realtime 80.08 +0.11 (+0.14%) 09:28 ET
Quote Overview for Thu, Mar 20th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
74.90
Day High
80.26
Open 80.18
Previous Close 79.97 79.97
Volume 1,758,223 1,758,223
Avg Vol 1,955,316 1,955,316
Stochastic %K 8.43% 8.43%
Weighted Alpha -52.79 -52.79
5-Day Change -23.76 (-24.16%) -23.76 (-24.16%)
52-Week Range 73.06 - 173.25 73.06 - 173.25
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,759,648
  • Shares Outstanding, K 97,032
  • Annual Sales, $ 1,902 M
  • Annual Income, $ 235,240 K
  • EBIT $ 220 M
  • EBITDA $ 218 M
  • 60-Month Beta 0.79
  • Price/Sales 3.75
  • Price/Cash Flow 30.19
  • Price/Book 4.60

Options Overview Details

View History
  • Implied Volatility 54.49% ( +0.35%)
  • Historical Volatility 102.58%
  • IV Percentile 72%
  • IV Rank 19.35%
  • IV High 147.45% on 05/29/24
  • IV Low 32.18% on 01/22/25
  • Put/Call Vol Ratio 0.66
  • Today's Volume 4,774
  • Volume Avg (30-Day) 3,301
  • Put/Call OI Ratio 0.47
  • Today's Open Interest 54,730
  • Open Int (30-Day) 31,903

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 1.80
  • Number of Estimates 6
  • High Estimate 2.31
  • Low Estimate 1.50
  • Prior Year 0.38
  • Growth Rate Est. (year over year) +373.68%

Price Performance

See More
Period Period Low Period High Performance
1-Month
73.06 +2.11%
on 03/18/25
Period Open: 108.41
110.00 -32.18%
on 02/21/25
-33.81 (-31.18%)
since 02/20/25
3-Month
73.06 +2.11%
on 03/18/25
Period Open: 118.97
129.84 -42.54%
on 01/07/25
-44.36 (-37.29%)
since 12/20/24
52-Week
73.06 +2.11%
on 03/18/25
Period Open: 126.08
173.25 -56.94%
on 06/21/24
-51.47 (-40.83%)
since 03/20/24

Most Recent Stories

More News
Company News for Mar 19, 2025

Shares of Sarepta Therapeutics, Inc. SRPT plunged 27.4% after the company reported a patient death linked to its Elevidys gene therapy, sparking safety concerns.IHS Holding Limited IHS shares surged 13.2%...

BTU : 13.76 (-1.71%)
IHS : 4.81 (+6.42%)
SRPT : 74.30 (-7.09%)
MRP : 25.31 (-0.32%)
Stocks Settle Lower as Megacap Tech Stocks Routed

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -1.07%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.62%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.66%. March E-mini...

MSTR : 299.98 (-1.40%)
GOOGL : 162.52 (-0.84%)
AAPL : 213.59 (-0.77%)
ETR : 84.48 (-0.21%)
SRPT : 74.30 (-7.09%)
ADI : 205.38 (-2.19%)
ELV : 433.56 (+0.72%)
TSLA : 234.49 (-0.58%)
WTW : 334.49 (-0.01%)
SPY : 565.80 (-0.23%)
META : 595.00 (+1.87%)
MU : 103.29 (+1.21%)
Patient dies following muscular dystrophy gene therapy, Sarepta reports

A patient has died while taking a closely watched gene therapy for muscular dystrophy

SRPT : 74.30 (-7.09%)
$SPX : 5,659.13 (-0.28%)
$DOWI : 41,935.18 (-0.07%)
$IUXX : 19,656.08 (-0.41%)
Why Sarepta Therapeutics (SRPT) Shares Are Sliding Today

Why Sarepta Therapeutics (SRPT) Shares Are Sliding Today

SRPT : 74.30 (-7.09%)
Stocks Retreat on Weakness in Technology Stocks

The S&P 500 Index ($SPX ) (SPY ) today is down -1.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.67%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.89%. March E-mini S&P futures...

MSTR : 299.98 (-1.40%)
GOOGL : 162.52 (-0.84%)
UAL : 73.65 (-1.05%)
CVS : 68.45 (+0.80%)
ETR : 84.48 (-0.21%)
AVGO : 190.21 (-2.45%)
SRPT : 74.30 (-7.09%)
$IUXX : 19,656.08 (-0.41%)
UNH : 510.22 (+1.40%)
ELV : 433.56 (+0.72%)
ZNM25 : 111-040 (+0.11%)
MSFT : 386.14 (-0.43%)
Stocks Slide on Economic Growth Concerns

The S&P 500 Index ($SPX ) (SPY ) today is down -1.01%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.50%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.73%. March E-mini S&P futures...

MSTR : 299.98 (-1.40%)
GOOGL : 162.52 (-0.84%)
MPC : 151.04 (+0.98%)
ETR : 84.48 (-0.21%)
AVGO : 190.21 (-2.45%)
SRPT : 74.30 (-7.09%)
$IUXX : 19,656.08 (-0.41%)
BWA : 28.97 (-0.17%)
ZNM25 : 111-040 (+0.11%)
MSFT : 386.14 (-0.43%)
TSLA : 234.49 (-0.58%)
ESM25 : 5,713.25 (-0.29%)
Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4

Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4

SRPT : 74.30 (-7.09%)
MYGN : 9.76 (-1.71%)
BMRN : 71.73 (+0.57%)
ABBV : 211.47 (-0.37%)
MRNA : 33.17 (-0.45%)
Sarepta Therapeutics (SRPT) Q4 2024 Earnings Call Transcript

SRPT earnings call for the period ending December 31, 2024.

SRPT : 74.30 (-7.09%)
Sarepta Therapeutics’s (NASDAQ:SRPT) Q4: Beats On Revenue

Sarepta Therapeutics’s (NASDAQ:SRPT) Q4: Beats On Revenue

SRPT : 74.30 (-7.09%)
Sarepta Therapeutics: Q4 Earnings Snapshot

Sarepta Therapeutics: Q4 Earnings Snapshot

SRPT : 74.30 (-7.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company that focuses on the discovery and development of RNA-based therapeutics targeting rare and infectious diseases. It concentrates on the development of exon-skipping drug candidates targeting Duchenne muscular dystrophy (DMD), a...

See More

Key Turning Points

3rd Resistance Point 88.11
2nd Resistance Point 84.55
1st Resistance Point 82.26
Last Price 74.30
1st Support Level 76.40
2nd Support Level 72.84
3rd Support Level 70.55

See More

52-Week High 173.25
Fibonacci 61.8% 134.98
Fibonacci 50% 123.15
Fibonacci 38.2% 111.33
Last Price 74.30
52-Week Low 73.06

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals